Aurinia Pharmaceuticals
AUPH
#4701
Rank
HK$17.32 B
Marketcap
HK$129.31
Share price
0.18%
Change (1 day)
11.67%
Change (1 year)

EPS for Aurinia Pharmaceuticals (AUPH)

EPS in 2023 (TTM): -HK$4.15

According to Aurinia Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is HK$18.74. In 2022 the company made an earnings per share (EPS) of -HK$5.96 an increase over its 2021 EPS that were of -HK$11.06.

EPS history for Aurinia Pharmaceuticals from 1999 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$4.15-30.35%
2022-HK$5.96-46.1%
2021-HK$11.0663.95%
2020-HK$6.74-33.85%
2019-HK$10.1973.33%
2018-HK$5.88-34.78%
2017-HK$9.0274.24%
2016-HK$5.1813.79%
2015-HK$4.55-15.94%
2014-HK$5.4161.51%
2013-HK$3.35-83.03%
2012-HK$19.74621.77%
2011-HK$2.74-75.81%
2010-HK$11.31-53.29%
2009-HK$24.21-59.15%
2008-HK$59.26-50.57%
2007-HK$119.9016.07%
2006-HK$103.30-28.86%
2005-HK$145.2025.38%
2004-HK$115.8151.08%
2003-HK$76.664032.42%
2002-HK$1.86
2000-HK$68.90290.68%
1999-HK$17.64

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Regeneron Pharmaceuticals
REGN
HK$328.64 1,653.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Pieris Pharmaceuticals
PIRS
-HK$138.01-836.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
-HK$16.07-185.73%๐Ÿ‡บ๐Ÿ‡ธ USA